These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2575488)

  • 1. Differential regulation of oncogenic and cellular p185 by serine/threonine kinases.
    Dobashi K; Weiner DB; Greene MI
    DNA; 1989 Dec; 8(10):723-32. PubMed ID: 2575488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TPA inhibits the tyrosine kinase activity of the neu protein in vivo and in vitro.
    Cao H; Decker S; Stern DF
    Oncogene; 1991 May; 6(5):705-11. PubMed ID: 1675782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products.
    Kokai Y; Dobashi K; Weiner DB; Myers JN; Nowell PC; Greene MI
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5389-93. PubMed ID: 2899889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of the normal and oncogenic forms of the neu tyrosine kinase, and the corresponding forms of an immunoglobulin E receptor/neu tyrosine kinase fusion protein, on Xenopus oocyte maturation.
    Narasimhan V; Hamill O; Cerione RA
    FEBS Lett; 1992 Jun; 303(2-3):164-8. PubMed ID: 1351469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linkage of tyrosine kinase activity with transforming ability of the p185neu oncoprotein.
    Weiner DB; Kokai Y; Wada T; Cohen JA; Williams WV; Greene MI
    Oncogene; 1989 Oct; 4(10):1175-83. PubMed ID: 2571965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutively activated neu oncoprotein tyrosine kinase interferes with growth factor-induced signals for gene activation.
    Lehtola L; Sistonen L; Koskinen P; Lehväslaiho H; Di Renzo MF; Comoglio PM; Alitalo K
    J Cell Biochem; 1991 Jan; 45(1):69-81. PubMed ID: 1706346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased tyrosine kinase activity associated with the protein encoded by the activated neu oncogene.
    Bargmann CI; Weinberg RA
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5394-8. PubMed ID: 2899890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the neu oncogene product in cell transformation and normal development.
    Kokai Y; Wada T; Myers JN; Brown VI; Dobashi K; Cohen J; Hamuro J; Weiner DB; Greene MI
    Princess Takamatsu Symp; 1988; 19():45-57. PubMed ID: 2908355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A point mutation in the neu oncogene mimics ligand induction of receptor aggregation.
    Weiner DB; Liu J; Cohen JA; Williams WV; Greene MI
    Nature; 1989 May; 339(6221):230-1. PubMed ID: 2654648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Aminopurine abolishes EGF- and TPA-stimulated pp33 phosphorylation and c-fos induction without affecting the activation of protein kinase C.
    Mahadevan LC; Wills AJ; Hirst EA; Rathjen PD; Heath JK
    Oncogene; 1990 Mar; 5(3):327-35. PubMed ID: 2107492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermolecular association and trans-phosphorylation of different neu-kinase forms permit SH2-dependent signaling and oncogenic transformation.
    Qian X; Dougall WC; Fei Z; Greene MI
    Oncogene; 1995 Jan; 10(1):211-9. PubMed ID: 7824275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand and p185c-neu density govern receptor interactions and tyrosine kinase activation.
    Samanta A; LeVea CM; Dougall WC; Qian X; Greene MI
    Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1711-5. PubMed ID: 7907421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical comparisons of the normal and oncogenic forms of insect cell-expressed neu tyrosine kinases.
    Guy PM; Carraway KL; Cerione RA
    J Biol Chem; 1992 Jul; 267(20):13851-6. PubMed ID: 1352772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic activation of p185neu stimulates tyrosine phosphorylation in vivo.
    Stern DF; Kamps MP; Cao H
    Mol Cell Biol; 1988 Sep; 8(9):3969-73. PubMed ID: 2464744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neu differentiation factor/heregulin modulates growth and differentiation of HC11 mammary epithelial cells.
    Marte BM; Jeschke M; Graus-Porta D; Taverna D; Hofer P; Groner B; Yarden Y; Hynes NE
    Mol Endocrinol; 1995 Jan; 9(1):14-23. PubMed ID: 7760847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGF-stimulated tyrosine phosphorylation of p185neu: a potential model for receptor interactions.
    Stern DF; Kamps MP
    EMBO J; 1988 Apr; 7(4):995-1001. PubMed ID: 3261240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of the epidermal growth factor receptor at threonine 654 inhibits ligand-induced internalization and down-regulation.
    Lund KA; Lazar CS; Chen WS; Walsh BJ; Welsh JB; Herbst JJ; Walton GM; Rosenfeld MG; Gill GN; Wiley HS
    J Biol Chem; 1990 Nov; 265(33):20517-23. PubMed ID: 2173710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase-c activation inhibits tyrosine phosphorylation of the c-met protein.
    Gandino L; Di Renzo MF; Giordano S; Bussolino F; Comoglio PM
    Oncogene; 1990 May; 5(5):721-5. PubMed ID: 2111905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 25 kDa polypeptide is the ligand for p185neu and is secreted by activated macrophages.
    Tarakhovsky A; Zaichuk T; Prassolov V; Butenko ZA
    Oncogene; 1991 Dec; 6(12):2187-96. PubMed ID: 1685016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GM3 content modulates the EGF-activated p185c-neu levels, but not those of the constitutively activated oncoprotein p185neu.
    Sottocornola E; Berra B; Colombo I
    Biochim Biophys Acta; 2003 Dec; 1635(2-3):55-66. PubMed ID: 14729068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.